After the policy change, Mayo Clinic is approaching 90% adoption of biosimilars, up from 5% in previous years, and produced $23 million in savings during the first 12 months of implementation.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
